Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.

Slides:



Advertisements
Similar presentations
Hepatitis B & Hepatitis C in HIV
Advertisements

Egyptian Guidelines For Management of Chronic Hepatitis B
1. Interpret a positive HBeAg, Anti- HBcAg, and/or anti-HCV test.
When, how and which patient to treat with HBV infection. David Mutimer Queen Elizabeth Hospital Birmingham, England. BSG Post-graduate Course March 20.
HBV and HIV HIV and HBV VG Naidoo Gastroenterology.
Hepatitis B.
Hepatitis B: Epidemiology
Iva Pitner Mentor: A. Žmegač Horvat
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
Kerriann Parchment GI CBL 2 Part 3 December 2012 Viral hepatitis serology.
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
HBV genotyping 12/21/07 Carrie Marshall. Received a send-out request for HBV genotyping on a 52y man.
Prevalence of Hepatitis B infection in married women of child bearing age in District Islamabad Dr. Najma Javeed Awan Senior Medical Officer Pakistan Medical.
EPIDEMIOLOGICAL AND CLINICAL FEATURES OF LIVER CIRRHOSIS
Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
Hepatitis B The Basics David Wong University of Toronto March 2005.
Viral Hepatitis.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
Hepatitis B Fahad Alanazi.
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
CHRONIC HEPATITIS B SEROLOGY
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
VIRAL HEPATITIS SUPERVISED BY: Dr Mohammad Rasheed PREPARED BY: Dr Rawan AL Soud.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Hepatitis B virus infection in renal transplant recipients
Viral Hepatitis.
Viral Hepatitis Andy King Consultant Gastroenterologist/Hepatologist
Hepatitis B and C Dr. Asif Rehman.
Hepatitis C.
National Hepatitis C Database
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
In The Name of God.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Achieving WHO Recommendations for HCV in the European Union
MICROBIOLOGY PRACTICAL
MICROBIOLOGY PRACTICAL
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Viral hepatitis Abdullah Alyouzbaki
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Knowledge of transmission Sharing of sharp objects
Prevalence of Hepatitis C Virus Genotypes in Bangladesh
Hepatology Hepatitis C virus (HCV) genotype 1b as a risk factor
Dr. Mohd. Shaker An Overview
Higher Prevalence of HbsAg among Blood Donors at a tertiary care center in greater Gwalior: A 5years study ( TTI-12 : D-1182 ) Dr. Anita Arya, Dr. Sachin.
MICROBIOLOGY PRACTICAL
DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV
Starting Strong: Initial Evaluation of the Patient With HCV
Achieving WHO Recommendations for HCV Elimination in the Western Pacific Region L. Wei April 13, 2016.
Volume 136, Issue 4, Pages (April 2009)
Hepatology Hepatitis C virus (HCV) genotype 1b as a risk factor
RISK R isk of Perinatal and Early Childhood Infection
Hepatitis Primary Care: Clinics in Office Practice
Volume 136, Issue 4, Pages (April 2009)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5 year open-label follow-up study Martin Gerbert,
Division of Viral Hepatitis
CHRONIC HEPATITIS B Dr.mousavi-Abadan CHRONIC HEPATITIS B Dr.mousavi-Abadan-1397.
Suna Yapali, Nizar Talaat, Anna S. Lok 
HEPATITIS C BY MBBSPPT.COM
Introduction The American Journal of Medicine
L. -W. Song, P. -G. Liu, C. -J. Liu, T. -Y. Zhang, X. -D. Cheng, H. -L
Impact of metabolic risk factors on HCC
Clinicaloptions.com/hepatitis Using Virologic and Serologic Tests in the Management of Hepatitis B Diagnose chronic HBV infection When in slideshow mode,
Progression of chronic Hepatitis B From beginning to end
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients  H.-Y. Pan, H.-Y. Pan,
Presentation transcript:

Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok

Worldwide Hepatitis B statistics: > 2 billion people (1/3 of the world’s population) have been exposed ,800 million infected persons , 350 million chronic carriers ,50 million new cases/year Accounts for 60-80 percent of liver cancer cases (the leading cause of liver cancer) Accounts for 500,000 to 1.2 million deaths per year (10th leading cause of death worldwide)

CHB infection Chronic infection is an even greater problem globally, affecting approximately 350 million persons. An estimated 620,000 persons worldwide die from HBV-related liver disease each year.

Factors Associated With Increased Risks of Progression to Cirrhosis Host Factors Virus Factors Environmental Factors Older age* High levels of Concurrent infection (longer duration) HBV replication* (HCV*, HDV, HIV) Male* Genotype (C B)* Alcohol consumption* Immune status HBV variant Diabetes mellitus† (core promoter) Obesity

WHO ;HBV; DCS,CRS,2002 Chronic HBV infection: 45% live in area of high endemicity( > 8% of population are +ve for HBsAg ) 43% live in moderate area ( 2 – 7 % of population are +ve for HBsAg ) 12% live in low areas ( < 2% )

Aims This study seeks to the prevalence of HBe Antigen in patients with chronic HBV infection and to correlate its presence to clinical severity of the disease , infectivity & relation to virus load

In this study Plasma were collected from 70 patients with positive HBs Antigen detected by ELIZA technique and in these patients we test HBe Ag , HBe Ab and HBc Ab by the same technique inaddition we do PCR test to measure the degree of viral load in these patients . All the patients had thorough clinical assessment , U\S examination , blood picture and liver function tests( BR, ALT , PT,and albumin ) .

Results 70 patients with HBsAg +ve , Symptomatic ( 37 ) , Asymptomatics ( 33 ) Demographic Characteristics : Age ( 12 – 70 )with mean of 40 years±8.8SD, <40 80% +ve , 27% - ve Gender M\F , HBeAg +ve 2:3, HBeAg - ve 4:1 Urban: HBeAg +ve 3\15, HBeAg – ve 15\55 Rural : HBeAg +ve 12\15, HBeAg – ve 40\55 HBeAg – Status : Negative 55 Positive 15

Results ( cont.) Low S. Albumin 33% +ve e , 30% -ve e PT prolonged in 40% +ve e , 23% -ve e ALT elevation higher in e +ve 80%\27% U\S changes in 25% e +ve ,while e –ve 17%

Results Viral Load of > 10copies \ml in 86% of HBeAg +ve & in 50% of e –ve ( P value < 0.05 ) Only 15 patients ( 32% ) of patients with AntiHBe Ab , have high viral load & viral DNA , whereas 55 patients , 68% of patients who donot have AntiHBe Ab have high viral load by PCR ( P < 0.05 ) The higher virus load FH +ve 34.1%. In Low virus load 17.9% had +ve FH

Results Summary From a total of 70 patients diagnosed as CLD according to the American Association of liver disease 15 found to have positive e antigen and about 85% of these patients are rural and 80% are symptomatic with abnormal LFTs and findings on liver U\S compared with e negative patients . Viral load of > 105copies \ ml .were reported in 87% of e antigen positive CHB in comparism to 50% in e antigen negative CHBV ( P value < 0.05 )

In conclusion 1 . The prevelance of e antigen positivity is 21 % among patients with CHBV infection in Babylon 2 . HBe Ag is a marker of severity & infectivity , but its absence does not exclude the infectivity rate as a good percentage of these patients had detectable levels of viral DNA .

In conclusion 3 . Persons older than 50 years of age are more HBeAg-negative & more likely to spontaneously clear HBsAg than any other group.

Recommendations Future studies should concentrate on determining the exact time infected persons contract chronic hepatitis B . Hepatitis B vaccination is the most efficient method of preventing HBV and HBV-related illnesses (1st anti-cancer vaccine). Future policy should also focus on improving medical services, detection, liver biopsy and treatment for chronic HBV carriers, especially in Asian populations where precore mutant HBeAg –ve is prevalent

Thank You Alsalam Alaikum